Clinical trial
REtroperitoneal SArcoma Registry (RESAR): Prospective Collection of Primary Retroperitoneal Sarcoma Patient's Data, Radiological and Pathological Material for the TransAtlantic Retroperitoneal Sarcoma Working Group
NCT03838718 is registered in ClinicalTrials.gov with Fondazione IRCCS Istituto Nazionale dei Tumori, Milano as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REtroperitoneal SArcoma Registry (RESAR): Prospective Collection of Primary Retroperitoneal Sarcoma Patient's Data, Radiological and Pathological Material for the TransAtlantic Retroperitoneal Sarcoma Working Group
- Lead sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2016
- Completion date
- December 31, 2030
- Enrollment
- 2,000 (estimated)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
retroperitoneal sarcoma